OncoKDM Lite: Improving TSO500 data interpretation accuracy from VCF files in oncology routine practice
contributed by OncoDNA |
Dr. Jean-François Laes
In the era of precision medicine, recent developments in next-generation sequencing and tumor immunology have allowed the discovery that several receptors like CTLA4, PD-1 and PD-L1 could be targeted by therapeutic monoclonal antibodies to cure patients.
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!
